Once again when our pps is surging to breakout highs....news that is expected at a major Conference is not given....and the pps retreats. I think most of us were expecting data on version 2 of LymPro. What we got was....NO ONE IS QUITE SURE? Amarantus' science is great, but their sense of timing leaves something to be desired. They couldn't be more unclear on how they've communicated these Lympro test results than if they had their worst Alzheimers patient do the PRs!!
Their science is great, but their ability to communicate clearly sucks!!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links